CN1173771C - Polyamide Composite Affinity Membrane for Purification of Immunoglobulin in Human Plasma and Its Preparation - Google Patents
Polyamide Composite Affinity Membrane for Purification of Immunoglobulin in Human Plasma and Its Preparation Download PDFInfo
- Publication number
- CN1173771C CN1173771C CNB001233386A CN00123338A CN1173771C CN 1173771 C CN1173771 C CN 1173771C CN B001233386 A CNB001233386 A CN B001233386A CN 00123338 A CN00123338 A CN 00123338A CN 1173771 C CN1173771 C CN 1173771C
- Authority
- CN
- China
- Prior art keywords
- membrane
- phenylalanine
- polyamide
- affinity
- film
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Fee Related
Links
- 239000012528 membrane Substances 0.000 title claims abstract description 69
- 108060003951 Immunoglobulin Proteins 0.000 title claims abstract description 22
- 239000004952 Polyamide Substances 0.000 title claims abstract description 22
- 102000018358 immunoglobulin Human genes 0.000 title claims abstract description 22
- 229920002647 polyamide Polymers 0.000 title claims abstract description 22
- 239000002131 composite material Substances 0.000 title claims abstract description 16
- 238000000746 purification Methods 0.000 title claims abstract description 11
- 238000002360 preparation method Methods 0.000 title claims description 6
- 229920000663 Hydroxyethyl cellulose Polymers 0.000 claims abstract description 25
- COLNVLDHVKWLRT-QMMMGPOBSA-N L-phenylalanine Chemical compound OC(=O)[C@@H](N)CC1=CC=CC=C1 COLNVLDHVKWLRT-QMMMGPOBSA-N 0.000 claims abstract description 23
- 239000004354 Hydroxyethyl cellulose Substances 0.000 claims abstract description 22
- COLNVLDHVKWLRT-UHFFFAOYSA-N phenylalanine Natural products OC(=O)C(N)CC1=CC=CC=C1 COLNVLDHVKWLRT-UHFFFAOYSA-N 0.000 claims abstract description 21
- 235000019447 hydroxyethyl cellulose Nutrition 0.000 claims abstract description 19
- 239000003446 ligand Substances 0.000 claims abstract description 17
- 238000000034 method Methods 0.000 claims description 14
- RYHBNJHYFVUHQT-UHFFFAOYSA-N 1,4-Dioxane Chemical compound C1COCCO1 RYHBNJHYFVUHQT-UHFFFAOYSA-N 0.000 claims description 12
- VEXZGXHMUGYJMC-UHFFFAOYSA-N Hydrochloric acid Chemical compound Cl VEXZGXHMUGYJMC-UHFFFAOYSA-N 0.000 claims description 12
- CTQNGGLPUBDAKN-UHFFFAOYSA-N O-Xylene Chemical compound CC1=CC=CC=C1C CTQNGGLPUBDAKN-UHFFFAOYSA-N 0.000 claims description 10
- CDBYLPFSWZWCQE-UHFFFAOYSA-L Sodium Carbonate Chemical compound [Na+].[Na+].[O-]C([O-])=O CDBYLPFSWZWCQE-UHFFFAOYSA-L 0.000 claims description 8
- 239000008096 xylene Substances 0.000 claims description 8
- 238000006243 chemical reaction Methods 0.000 claims description 7
- 230000004913 activation Effects 0.000 claims description 4
- 238000001035 drying Methods 0.000 claims description 4
- 229910000029 sodium carbonate Inorganic materials 0.000 claims description 4
- 238000003756 stirring Methods 0.000 claims description 4
- 239000000835 fiber Substances 0.000 claims description 2
- 230000007062 hydrolysis Effects 0.000 claims description 2
- 238000006460 hydrolysis reaction Methods 0.000 claims description 2
- RTNUTCOTGVKVBR-UHFFFAOYSA-N 4-chlorotriazine Chemical class ClC1=CC=NN=N1 RTNUTCOTGVKVBR-UHFFFAOYSA-N 0.000 claims 5
- 150000001875 compounds Chemical class 0.000 claims 2
- GAWIXWVDTYZWAW-UHFFFAOYSA-N C[CH]O Chemical group C[CH]O GAWIXWVDTYZWAW-UHFFFAOYSA-N 0.000 claims 1
- 229920002678 cellulose Polymers 0.000 claims 1
- 239000001913 cellulose Substances 0.000 claims 1
- 238000007654 immersion Methods 0.000 claims 1
- 210000002381 plasma Anatomy 0.000 abstract description 16
- 108010074605 gamma-Globulins Proteins 0.000 abstract description 13
- 238000011084 recovery Methods 0.000 abstract description 6
- 230000000694 effects Effects 0.000 abstract description 3
- 239000000243 solution Substances 0.000 description 23
- LZKGFGLOQNSMBS-UHFFFAOYSA-N 4,5,6-trichlorotriazine Chemical compound ClC1=NN=NC(Cl)=C1Cl LZKGFGLOQNSMBS-UHFFFAOYSA-N 0.000 description 14
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 10
- HEMHJVSKTPXQMS-UHFFFAOYSA-M Sodium hydroxide Chemical compound [OH-].[Na+] HEMHJVSKTPXQMS-UHFFFAOYSA-M 0.000 description 9
- 239000008367 deionised water Substances 0.000 description 9
- 229910021641 deionized water Inorganic materials 0.000 description 9
- 239000004677 Nylon Substances 0.000 description 7
- 229940072221 immunoglobulins Drugs 0.000 description 7
- 229920001778 nylon Polymers 0.000 description 7
- LYCAIKOWRPUZTN-UHFFFAOYSA-N Ethylene glycol Chemical compound OCCO LYCAIKOWRPUZTN-UHFFFAOYSA-N 0.000 description 6
- KFZMGEQAYNKOFK-UHFFFAOYSA-N Isopropanol Chemical compound CC(C)O KFZMGEQAYNKOFK-UHFFFAOYSA-N 0.000 description 6
- FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 description 6
- 102000004169 proteins and genes Human genes 0.000 description 5
- 108090000623 proteins and genes Proteins 0.000 description 5
- 229920002292 Nylon 6 Polymers 0.000 description 3
- 229920002684 Sepharose Polymers 0.000 description 3
- 238000000502 dialysis Methods 0.000 description 3
- 239000011780 sodium chloride Substances 0.000 description 3
- 229920000936 Agarose Polymers 0.000 description 2
- 101710120037 Toxin CcdB Proteins 0.000 description 2
- 238000001962 electrophoresis Methods 0.000 description 2
- 230000003993 interaction Effects 0.000 description 2
- 239000012982 microporous membrane Substances 0.000 description 2
- 239000002994 raw material Substances 0.000 description 2
- 238000001179 sorption measurement Methods 0.000 description 2
- WFYCZPSRMLYGSK-UHFFFAOYSA-N 1,4-dioxane;1,2-xylene Chemical group C1COCCO1.CC1=CC=CC=C1C WFYCZPSRMLYGSK-UHFFFAOYSA-N 0.000 description 1
- SHKUUQIDMUMQQK-UHFFFAOYSA-N 2-[4-(oxiran-2-ylmethoxy)butoxymethyl]oxirane Chemical compound C1OC1COCCCCOCC1CO1 SHKUUQIDMUMQQK-UHFFFAOYSA-N 0.000 description 1
- 239000011543 agarose gel Substances 0.000 description 1
- 125000003368 amide group Chemical group 0.000 description 1
- 125000003277 amino group Chemical group 0.000 description 1
- 238000004458 analytical method Methods 0.000 description 1
- 239000007864 aqueous solution Substances 0.000 description 1
- 229910052801 chlorine Inorganic materials 0.000 description 1
- 125000001309 chloro group Chemical group Cl* 0.000 description 1
- 230000000052 comparative effect Effects 0.000 description 1
- ATDGTVJJHBUTRL-UHFFFAOYSA-N cyanogen bromide Chemical compound BrC#N ATDGTVJJHBUTRL-UHFFFAOYSA-N 0.000 description 1
- 238000010828 elution Methods 0.000 description 1
- 238000005516 engineering process Methods 0.000 description 1
- 238000012869 ethanol precipitation Methods 0.000 description 1
- 125000002791 glucosyl group Chemical group C1([C@H](O)[C@@H](O)[C@H](O)[C@H](O1)CO)* 0.000 description 1
- 239000012535 impurity Substances 0.000 description 1
- 239000007788 liquid Substances 0.000 description 1
- 229920002521 macromolecule Polymers 0.000 description 1
- 239000011159 matrix material Substances 0.000 description 1
- 230000007935 neutral effect Effects 0.000 description 1
- 230000003472 neutralizing effect Effects 0.000 description 1
- FEMOMIGRRWSMCU-UHFFFAOYSA-N ninhydrin Chemical compound C1=CC=C2C(=O)C(O)(O)C(=O)C2=C1 FEMOMIGRRWSMCU-UHFFFAOYSA-N 0.000 description 1
- 239000003960 organic solvent Substances 0.000 description 1
- OQUKIQWCVTZJAF-UHFFFAOYSA-N phenol;sulfuric acid Chemical compound OS(O)(=O)=O.OC1=CC=CC=C1 OQUKIQWCVTZJAF-UHFFFAOYSA-N 0.000 description 1
- 239000002244 precipitate Substances 0.000 description 1
- 125000002924 primary amino group Chemical group [H]N([H])* 0.000 description 1
- 239000000047 product Substances 0.000 description 1
- 239000004627 regenerated cellulose Substances 0.000 description 1
- 150000003839 salts Chemical class 0.000 description 1
- 238000000926 separation method Methods 0.000 description 1
- 239000011734 sodium Substances 0.000 description 1
- 238000005406 washing Methods 0.000 description 1
- DGVVWUTYPXICAM-UHFFFAOYSA-N β‐Mercaptoethanol Chemical compound OCCS DGVVWUTYPXICAM-UHFFFAOYSA-N 0.000 description 1
Landscapes
- External Artificial Organs (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
- Separation Using Semi-Permeable Membranes (AREA)
Abstract
一种用于人血浆中免疫球蛋白纯化的聚酰胺复合亲和膜,其特征在于:该膜为键合有苯丙氨酸亲和配基的由羟乙基纤维素改性的聚酰胺微孔滤膜复合膜;羟乙基纤维素的量为每克膜150~225mg,苯丙氨酸亲和配基的量为每克膜150~180μmol。本发明对血浆中丙种球蛋白的纯化效果好,介质性能稳定,使用方便,回收率高。A polyamide composite affinity membrane used for purification of immunoglobulin in human plasma is characterized in that: the membrane is a polyamide microstructure modified by hydroxyethyl cellulose bonded with a phenylalanine affinity ligand. Porous filter membrane composite membrane; the amount of hydroxyethyl cellulose is 150-225 mg per gram of membrane, and the amount of phenylalanine affinity ligand is 150-180 μmol per gram of membrane. The invention has good purification effect on gamma globulin in blood plasma, stable medium performance, convenient use and high recovery rate.
Description
本发明涉及分离膜技术,特别提供了一种用于人血浆中免疫球蛋白纯化的聚酰胺复合亲和膜及制备方法。The invention relates to separation membrane technology, and particularly provides a polyamide composite affinity membrane used for purifying immunoglobulin in human blood plasma and a preparation method thereof.
目前文献报道的免疫球蛋白纯化方法,大多数是用乙醇沉淀法获得的,但它只能将各种免疫球蛋白一起沉淀下来,不能将不同种类的免疫球蛋白分离开,所得产品纯度也不理想。有人采用以琼脂糖、再生纤维素、尼龙膜为原料,固载化上A蛋白或G蛋白,特异性地吸附血浆中的免疫球蛋白,再用盐和有机溶剂将上述介质上吸附的免疫球蛋白脱附下来。然而这种方法由于A蛋白和G蛋白制备起来十分麻烦,价格也十分昂贵,洗脱过程中还有可能造成免疫球蛋白的失活和变性,也未能获得推广应用。此外还有人在琼脂糖Sepharose上固载化上一种外源性凝集素-Jacalin,也可纯化免疫球蛋白,但所得免疫球蛋白的纯度和回收率都不很理想。Most of the immunoglobulin purification methods reported in the literature are obtained by ethanol precipitation, but it can only precipitate various immunoglobulins together, and cannot separate different types of immunoglobulins, and the purity of the obtained products is not high. ideal. Some people use agarose, regenerated cellulose, and nylon membranes as raw materials to immobilize protein A or protein G to specifically adsorb immunoglobulins in plasma, and then use salt and organic solvents to absorb the immunoglobulins adsorbed on the above media. The protein is desorbed. However, this method has not been popularized and applied because the preparation of protein A and protein G is very troublesome, the price is also very expensive, and the immunoglobulin may be inactivated and denatured during the elution process. In addition, some people immobilized an exogenous lectin-Jacalin on agarose Sepharose, which can also purify immunoglobulins, but the purity and recovery rate of the obtained immunoglobulins are not very satisfactory.
本发明的目的在于提供一种用于人血浆中免疫球蛋白纯化的聚酰胺复合亲和膜及制备方法,其具有较高的丙种球蛋白质亲和容量,并且所得丙种球蛋白具有较高的纯度。The object of the present invention is to provide a polyamide composite affinity membrane and preparation method for the purification of immunoglobulin in human plasma, which has higher gamma globulin affinity capacity, and the obtained gamma globulin has higher purity .
本发明提供了一种用于人血浆中免疫球蛋白纯化的聚酰胺复合亲和膜,其特征在于:该膜为键合有苯丙氨酸亲和配基的由羟乙基纤维素改性的聚酰胺微孔滤膜复合膜;羟乙基纤维素的量为每克膜150~225mg,苯丙氨酸亲和配基的量为每克膜150~180μmol。The invention provides a polyamide composite affinity membrane for the purification of immunoglobulin in human plasma, which is characterized in that: the membrane is a hydroxyethyl cellulose modified membrane bonded with a phenylalanine affinity ligand. Polyamide microporous membrane composite membrane; the amount of hydroxyethyl cellulose is 150-225 mg per gram of membrane, and the amount of phenylalanine affinity ligand is 150-180 μmol per gram of membrane.
本发明还提供了上述用于人血浆中免疫球蛋白纯化的聚酰胺复合亲和膜的制备方法,其特征在于:The present invention also provides the preparation method of the polyamide composite affinity membrane used for the purification of immunoglobulin in human plasma, characterized in that:
将聚酰胺微孔滤膜(尼龙6膜)用浓盐酸进行水解;The polyamide microporous membrane (nylon 6 membrane) is hydrolyzed with concentrated hydrochloric acid;
取1g水解后的聚酰胺膜,放入50~150ml含30~60%二氧六环的二甲苯体系中,再向该体系中分别加入0.5~1g的三氯三嗪法进行活化,反应在室温下进行30~60分钟;Take 1g of the hydrolyzed polyamide film, put it into 50-150ml xylene system containing 30-60% dioxane, and then add 0.5-1g of trichlorotriazine to the system for activation. 30-60 minutes at room temperature;
经三氯三嗪活化后的膜再浸入含1~5%羟乙基纤维素溶液中,并加入碳酸钠,使溶液pH值保持在6~7之间,于40~60℃下反应2~4小时;The membrane activated by trichlorotriazine is then immersed in a solution containing 1-5% hydroxyethyl cellulose, and sodium carbonate is added to keep the pH value of the solution between 6 and 7, and react at 40-60°C for 2- 4 hours;
将复合了羟乙基纤维素的膜减压干燥后,再次浸入上述含三氯三嗪的二氧六环/二甲苯溶液中,加入苯丙氨酸,在40~50℃反应4~5小时。After drying the film compounded with hydroxyethyl cellulose under reduced pressure, immerse it again in the dioxane/xylene solution containing trichlorotriazine, add phenylalanine, and react at 40-50°C for 4-5 hours .
本发明与现有技术的区别在于:The difference between the present invention and prior art is:
1.首次选用微孔尼龙6膜为原料,用三氯三嗪法进行活化,共价键合上了羟乙基纤维素,大大增加了膜上可反应基团的数目,并减少了对除免疫球蛋白以外蛋白质的非特异性吸附;1. For the first time, the microporous nylon 6 membrane was selected as the raw material, activated by the trichlorotriazine method, and hydroxyethyl cellulose was covalently bonded, which greatly increased the number of reactive groups on the membrane and reduced the resistance to removal. Non-specific adsorption of proteins other than immunoglobulins;
2.首次在所制备的尼龙6-羟乙基纤维素复合膜上选用二氧六环-二甲苯体系,通过与三氯三嗪上活泼氯原子的反应键合上了苯丙氨酸亲和配基,使膜上配基数目高达150~180μmol/g,大大提高了介质的亲和容量;2. For the first time, the dioxane-xylene system was selected on the prepared nylon 6-hydroxyethyl cellulose composite membrane, and the phenylalanine affinity was bonded to the active chlorine atom on the trichlorotriazine. Ligands make the number of ligands on the membrane as high as 150-180 μmol/g, which greatly improves the affinity capacity of the medium;
3.在所选用的最佳亲和条件下,该亲和膜对人血浆中丙种球蛋白质亲和容量可达15~25mg/g膜,比普通亲和介质高50%左右,所得丙种球蛋白的纯度为80~85%。3. Under the selected optimal affinity conditions, the affinity membrane for gamma globulin in human plasma can reach 15-25 mg/g membrane, which is about 50% higher than that of ordinary affinity media, and the obtained gamma globulin The purity is 80-85%.
总之,本发明所研制的亲和膜具有配基键合量高,对血浆中丙种球蛋白的纯化效果好,介质性能稳定,使用方便,回收率高等特点,是制取高纯度免疫球蛋白的有效工具和手段,具有很强的实用性和推广应用价值。In a word, the affinity membrane developed by the present invention has the characteristics of high ligand binding capacity, good purification effect on gamma globulin in plasma, stable medium performance, convenient use, high recovery rate, etc., and is the best choice for producing high-purity immunoglobulin. Effective tools and means have strong practicability and promotion and application value.
下面通过实施例详述本发明。The present invention is described in detail below by way of examples.
实施例1Example 1
首先将聚酰胺微孔滤膜(尼龙6膜)用浓盐酸进行水解,使膜上的酰胺基尽可能多地转变为伯氨基,水解前后膜上氨基数目用改进的茚三酮法进行定量测定。First, the polyamide microporous filter membrane (nylon 6 membrane) is hydrolyzed with concentrated hydrochloric acid, so that the amide groups on the membrane are converted into primary amino groups as much as possible, and the number of amino groups on the membrane before and after hydrolysis is quantitatively determined by the improved ninhydrin method .
水解后的聚酰胺膜用NaOH溶液浸泡,并充分中和掉剩余的HCl后,用D-H2O进行充分洗涤、抽滤,并进行真空干燥,然后用三氯三嗪法(CyCl3)进行活化,按1g聚酰胺膜加入0.8g的三氯三嗪计,反应在1∶1(V/V)二氧六环/二甲苯体系中进行,在室温下反应进行60分钟,反应结束后,先用二氧六环,再用大量D-H2O进行充分洗涤,并减压真空干燥。The hydrolyzed polyamide membrane is soaked in NaOH solution, and after fully neutralizing the remaining HCl, it is fully washed with DH 2 O, suction filtered, and vacuum-dried, and then activated by the trichlorotriazine method (CyCl 3 ) , add 0.8g trichlorotriazine meter according to 1g polyamide membrane, react in 1: 1 (V/V) dioxane/xylene system, carry out reaction at room temperature for 60 minutes, after reaction finishes, first Wash thoroughly with dioxane and a large amount of DH 2 O, and dry under reduced pressure in vacuo.
经三氯三嗪活化后的膜再浸入含3%羟乙基纤维素溶液中,并加入适量碳酸钠,使溶液pH值保持在6~7之间。于60℃下反应4小时,然后用0.1mol NaOH溶液洗3次,再用大量水洗,并减压抽干;采用酚-硫酸法测定尼龙膜上复合的羟乙基纤维素的量,按纤维素分子上葡萄糖单元计。复合了羟乙基纤维素的膜比原始尼龙膜上可反应的基团数增加约17倍,复合膜还大大减少了对除免疫球蛋白以外生物大分子的非特异性吸附。The membrane activated by trichlorotriazine is then immersed in a solution containing 3% hydroxyethyl cellulose, and an appropriate amount of sodium carbonate is added to keep the pH value of the solution between 6 and 7. React at 60°C for 4 hours, then wash 3 times with 0.1mol NaOH solution, wash with a large amount of water, and dry under reduced pressure; use the phenol-sulfuric acid method to determine the amount of hydroxyethyl cellulose composited on the nylon membrane, according to the fiber Glucose unit on the element molecule. The membrane compounded with hydroxyethyl cellulose has about 17 times more reactive groups than the original nylon membrane, and the composite membrane also greatly reduces the non-specific adsorption of biological macromolecules other than immunoglobulin.
将复合了羟乙基纤维素的膜减压干燥后,再次浸入上述含三氯三嗪的二氧六环/二甲苯溶液中,加入苯丙氨酸,在40~50℃搅拌下反应5小时,然后分别用二氧六环、异丙醇溶液和去离子水彻底洗涤,并减压干燥,这样就制成了含苯丙氨酸亲和配基的尼龙6-羟乙基纤维素复合亲和膜,每克膜上苯丙氨酸的含量可达165μmol。After drying the film compounded with hydroxyethyl cellulose under reduced pressure, immerse it again in the dioxane/xylene solution containing trichlorotriazine, add phenylalanine, and react for 5 hours under stirring at 40-50°C , and then washed thoroughly with dioxane, isopropanol solution and deionized water, and dried under reduced pressure, so that the nylon 6-hydroxyethyl cellulose composite affinity ligand containing phenylalanine was made And membrane, the content of phenylalanine per gram of membrane can reach 165μmol.
将按上述方法制备的20张直径为47mm带苯丙氨酸配位基的亲和膜,装配在碟式亲和膜分离器中。用0.05mol/L NaH2PO4溶液稀释4ml人血浆,将血浆稀释液以1ml/min的流速泵入亲和膜分离器,使膜上苯丙氨酸配位基与丙种球蛋白产生亲和相互作用。先用1mol/L氯化钠溶液50ml在2ml/min流速下洗涤掉膜上残留的杂蛋白,再改用1mol/L氯化钠/乙二醇(1∶1,V/V),在同样流量下洗脱膜上亲和吸附的免疫球蛋白(γ-Globulin),收集洗脱液,用透析袋透析后,将样品做电泳分析,证明所得丙种免疫球蛋白质纯度为83.5%。血浆中丙种球蛋白的回收率可达78%,比其它纯化方法的回收率高。The 20 affinity membranes with a diameter of 47 mm and phenylalanine ligands prepared by the above method were assembled in a disc-type affinity membrane separator. Dilute 4ml of human plasma with 0.05mol/L NaH 2 PO 4 solution, and pump the diluted plasma solution into the affinity membrane separator at a flow rate of 1ml/min to make the phenylalanine ligand on the membrane and gamma globulin generate affinity interaction. First use 50ml of 1mol/L sodium chloride solution at a flow rate of 2ml/min to wash off the remaining impurity proteins on the membrane, then use 1mol/L sodium chloride/ethylene glycol (1:1, V/V) instead, in the same The affinity-adsorbed immunoglobulin (γ-Globulin) on the membrane was eluted under the flow rate, and the eluate was collected. After dialysis with a dialysis bag, the sample was analyzed by electrophoresis, which proved that the purity of the obtained gamma immunoglobulin was 83.5%. The recovery rate of gamma globulin in plasma can reach 78%, which is higher than that of other purification methods.
实施例2Example 2
将实施例1水解后的聚酰胺膜用NaOH溶液浸泡,并充分中和掉剩余的HCl后,用D-H2O进行充分洗涤、抽滤,并进行真空干燥,然后用三氯三嗪法(CyCl3)进行活化,按1g聚酰胺膜加入1g的三氯三嗪计,反应在1∶1(V/V)二氧六环/二甲苯体系中进行。Soak the hydrolyzed polyamide membrane in Example 1 with NaOH solution, and fully neutralize the remaining HCl, then fully wash with DH 2 O, suction filter, and vacuum-dry, and then use the trichlorotriazine method (CyCl 3 ) To activate, add 1 g of trichlorotriazine to 1 g of polyamide membrane, and the reaction is carried out in a 1:1 (V/V) dioxane/xylene system.
经三氯三嗪活化后的膜再浸入含5%羟乙基纤维素溶液中,并加入适量碳酸钠,使溶液pH值保持在6~7之间。复合了羟乙基纤维素的膜比原始尼龙膜上可反应的基团数增加约20倍。The membrane activated by trichlorotriazine is then immersed in a solution containing 5% hydroxyethyl cellulose, and an appropriate amount of sodium carbonate is added to keep the pH value of the solution between 6 and 7. The membrane compounded with hydroxyethyl cellulose has about 20 times more reactive groups than the original nylon membrane.
将复合了羟乙基纤维素的膜减压干燥后,再次浸入上述含三氯三嗪的二氧六环/二甲苯溶液中,加入苯丙氨酸,在40~50℃搅拌下反应5小时,然后分别用二氧六环、异丙醇溶液和去离子水彻底洗涤,并减压干燥,这样就制成了含苯丙氨酸亲和配基的尼龙6-羟乙基纤维素复合亲和膜,每克膜上苯丙氨酸的含量可达175μmol。After drying the film compounded with hydroxyethyl cellulose under reduced pressure, immerse it again in the dioxane/xylene solution containing trichlorotriazine, add phenylalanine, and react for 5 hours under stirring at 40-50°C , and then washed thoroughly with dioxane, isopropanol solution and deionized water, and dried under reduced pressure, so that the nylon 6-hydroxyethyl cellulose composite affinity ligand containing phenylalanine was made And the film, the content of phenylalanine per gram of film can reach 175μmol.
实施例3Example 3
1g经盐酸水解的聚酰胺膜浸入20ml含25mmol/L Na2CO3(pH8.0)和1,4-丁二醇二缩水甘油醚(BDE)的反应体系中,于40℃-50℃下边搅拌边反应8-10h。反应结束后,分别用1∶1的异丙醇/去离子水(D-H2O)及去离子水大量抽洗膜,以彻底洗掉未反应的BDE。然后再将膜浸入含2%HEC(HEC为羟乙基纤维素)的水溶液中,用2mol/L KOH溶液将pH值调至11,于25℃-35℃下反应2-3h,分别用0.5mol/L NaHCO3溶液和去离子水彻底抽洗至洗涤液呈中性。将结合了HEC的聚酰胺膜置入由20ml去离子水,4ml BDE和80mg KBH4组成的反应溶液中于25℃-35℃下反应2-4h,然后用大量去离子水冲洗膜。再将洗净的膜置入20ml由0.5mol/L NaHCO3和100mg苯丙氨酸(Phe)组成的溶液中于60-70℃下反应2-4h,室温下放置过夜。再用去离子水将反应后的膜彻底洗净,并浸入0.2mol/L β-巯基乙醇溶液(pH7.0)中,室温下放置4h,期间经常搅拌膜,以封闭膜上未反应的活性基团,再用去离子水彻底洗净,真空干燥。经测定该膜上键合的亲和配基(Phe)含量为205μmol/g,略高于用三氯三嗪键合法制备的亲和膜。Immerse 1g of polyamide membrane hydrolyzed by hydrochloric acid in 20ml of reaction system containing 25mmol/L Na 2 CO 3 (pH8.0) and 1,4-butanediol diglycidyl ether (BDE), at 40°C-50°C React while stirring for 8-10h. After the reaction, wash the membrane with 1:1 isopropanol/deionized water (DH 2 O) and deionized water in large quantities to completely wash away unreacted BDE. Then immerse the membrane in an aqueous solution containing 2% HEC (HEC is hydroxyethyl cellulose), adjust the pH value to 11 with 2mol/L KOH solution, react at 25°C-35°C for 2-3h, and use 0.5 mol/L NaHCO 3 solution and deionized water to wash thoroughly until the washing liquid is neutral. Put the polyamide membrane combined with HEC into the reaction solution consisting of 20ml deionized water, 4ml BDE and 80mg KBH 4 to react at 25°C-35°C for 2-4h, and then wash the membrane with a large amount of deionized water. Then put the washed membrane into 20ml of a solution consisting of 0.5mol/L NaHCO 3 and 100mg of phenylalanine (Phe) to react at 60-70°C for 2-4h, and leave it overnight at room temperature. The reacted membrane was then thoroughly washed with deionized water, immersed in a 0.2mol/L β-mercaptoethanol solution (pH 7.0), and left at room temperature for 4 hours, during which the membrane was often stirred to seal the unreacted activity on the membrane. groups, washed thoroughly with deionized water, and dried in vacuum. The content of the bound affinity ligand (Phe) on the membrane was determined to be 205 μmol/g, slightly higher than that of the affinity membrane prepared by the trichlorotriazine bonding method.
将20张所制备的亲和膜装入直径为47mm的碟式亲和膜分离器中,让5ml含0.05mol/L NaH2PO4溶液的人血浆样品以1ml/min的流速泵入此分离器中,使膜上的配基与血浆中的丙种球蛋白产生亲和相互作用。先用25ml1mol/L NaCl/乙二醇(1∶1,V/V)在同样流量下洗脱膜上亲和的丙种球蛋白,收集洗脱液,经透析后,用电泳做纯度分析,证明该丙种球蛋白的纯度为86.4%,回收率为82.0%,略高于三氯三嗪法。Put 20 prepared affinity membranes into a disc-type affinity membrane separator with a diameter of 47 mm, and pump 5 ml of human plasma samples containing 0.05 mol/L NaH 2 PO 4 solution into the separator at a flow rate of 1 ml/min. In the device, the ligands on the membrane have affinity interactions with the gamma globulin in the plasma. First use 25ml1mol/L NaCl/ethylene glycol (1:1, V/V) to elute the gamma globulin with affinity on the membrane at the same flow rate, collect the eluate, and after dialysis, use electrophoresis for purity analysis to prove The gamma globulin has a purity of 86.4% and a recovery rate of 82.0%, slightly higher than the trichlorotriazine method.
比较例comparative example
国外文献报道采用Pharmacia公司生产的琼脂糖凝胶Sepharose 4B为基质材料,用溴化氰活化法键合上苯丙氨酸配位基,配基键合量为78μmol/ml,低于本发明的键合量。用此亲和介质装填的一支体积约为20mlSepharose 4B-Phe亲和柱,一次纯化5ml血浆样品,所得免疫球蛋白的纯度为80~82%,略低于本发明。血浆中丙种球蛋白的回收率为75%。接近于本发明的结果。Foreign literature reports adopt the agarose gel Sepharose 4B produced by Pharmacia Company as the matrix material, and use the cyanogen bromide activation method to bond the phenylalanine ligand, and the ligand bonding amount is 78 μ mol/ml, which is lower than that of the present invention. Amount of bonding. A Sepharose 4B-Phe affinity column with a volume of about 20ml packed with this affinity medium can once purify 5ml plasma samples, and the purity of the resulting immunoglobulin is 80-82%, which is slightly lower than the present invention. The recovery rate of gamma globulin in plasma was 75%. close to the results of the present invention.
Claims (2)
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CNB001233386A CN1173771C (en) | 2000-11-29 | 2000-11-29 | Polyamide Composite Affinity Membrane for Purification of Immunoglobulin in Human Plasma and Its Preparation |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CNB001233386A CN1173771C (en) | 2000-11-29 | 2000-11-29 | Polyamide Composite Affinity Membrane for Purification of Immunoglobulin in Human Plasma and Its Preparation |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| CN1355064A CN1355064A (en) | 2002-06-26 |
| CN1173771C true CN1173771C (en) | 2004-11-03 |
Family
ID=4589789
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CNB001233386A Expired - Fee Related CN1173771C (en) | 2000-11-29 | 2000-11-29 | Polyamide Composite Affinity Membrane for Purification of Immunoglobulin in Human Plasma and Its Preparation |
Country Status (1)
| Country | Link |
|---|---|
| CN (1) | CN1173771C (en) |
Families Citing this family (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP3954725B1 (en) | 2019-04-08 | 2024-03-06 | Asahi Kasei Medical Co., Ltd. | Polyamide medium for purifying protein-containing solution and method for producing polyamide medium |
-
2000
- 2000-11-29 CN CNB001233386A patent/CN1173771C/en not_active Expired - Fee Related
Also Published As
| Publication number | Publication date |
|---|---|
| CN1355064A (en) | 2002-06-26 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| AU2016250389B2 (en) | Separation material comprising saccharide ligands | |
| EP3757123A1 (en) | Mutated immunoglobulin-binding polypeptides | |
| JPH0214325B2 (en) | ||
| JP5396933B2 (en) | Liquid chromatography packing and biopolymer separation and purification method | |
| CN100346872C (en) | Novel silica gel loaded cross-linked chitosan adsorbent for heavy metal | |
| Kubota et al. | Recovery of serum proteins using cellulosic affinity membrane modified by immobilization of Cu2+ ion | |
| JPWO2015041218A1 (en) | Novel antibody purification method and antibody obtained therefrom (Novel Antibody Purification Method), and novel antibody purification method using cation exchange group and novel antibody purification antibody method | |
| JPH0626667B2 (en) | Cyclodextrin adsorbent and its application | |
| US8999157B2 (en) | Method for preparation of a biomolecule adsorbent | |
| CN101596422A (en) | Preparation method of polyvinylidene fluoride affinity membrane with amino acid as ligand | |
| CN1130386A (en) | Heparin functional affinity supports | |
| CN107243336B (en) | Chromatography medium, preparation method and application thereof | |
| CN104211769A (en) | Micromolecule antibody affinity peptide and applications thereof | |
| CN102407098A (en) | A preparation method of immunoaffinity chromatography medium and its application in purifying tetrodotoxin | |
| CN1173771C (en) | Polyamide Composite Affinity Membrane for Purification of Immunoglobulin in Human Plasma and Its Preparation | |
| CN100446844C (en) | A kind of preparation method and application of nylon affinity membrane | |
| CN1195225C (en) | Process for preparing affinity chromatographic medium of metal chelating from acetate fibres | |
| CN112156499A (en) | Metal chelating chromatography filler and preparation method thereof | |
| JP2010145240A (en) | Liquid chromatography filler for immobilizing hydrophobic amino acid or aminomethyl benzoic acid, and method for separating, refining, collecting and recovering biological polymer using the same | |
| CN101185881A (en) | Chromatography medium for separation and purification of immunoglobulin proteins and preparation method thereof | |
| CN116262222B (en) | Preparation method of diethylaminoethyl natural polysaccharide chromatographic medium | |
| JPS6119485A (en) | Adsorbent for protease | |
| CN1093428C (en) | Chemical modification of microporous nylon film and preparation of affinity film with histidine ligand | |
| CN100398646C (en) | Preparation method of a novel affinity carrier | |
| WO2004078828A1 (en) | Agent for capturing substance having anionic substituent |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| C06 | Publication | ||
| PB01 | Publication | ||
| C10 | Entry into substantive examination | ||
| SE01 | Entry into force of request for substantive examination | ||
| C14 | Grant of patent or utility model | ||
| GR01 | Patent grant | ||
| C19 | Lapse of patent right due to non-payment of the annual fee | ||
| CF01 | Termination of patent right due to non-payment of annual fee |